Patrick C. Johnson, Md

This study tests whether adding the drug acalabrutinib to a CAR T-cell therapy called liso-cel can help people with aggressive B-cell lymphoma that has come back or not responded to treatment. About 28 adults will receive the combination and be monitored for tumor shrinkage and s…